Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""van Haren SD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
    Autorzy:
    Sherman AC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Crombie JL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Cheng C; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.; School of Pharmacy, National Taiwan University, Taipei, Taiwan.
    Desjardins M; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
    Zhou G; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
    Ometoruwa O; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
    Rooks R; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
    Senussi Y; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
    McDonough M; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Guerrero LI; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Kupelian J; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
    Doss-Gollin S; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
    Smolen KK; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    van Haren SD; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Armand P; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Levy O; Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT & Harvard, Cambridge, Massachusetts, USA.
    Walt DR; Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
    Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Issa NC; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Aug 16; Vol. 9 (8), pp. ofac417. Date of Electronic Publication: 2022 Aug 16 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    Autorzy:
    van Haren SD; Department of Plasma Proteins, Sanquin-AMC Landsteiner and Van Creveld Laboratory, Amsterdam, The Netherlands.
    Wroblewska A
    Herczenik E
    Kaijen PH
    Ruminska A
    ten Brinke A
    Meijer AB
    Voorberg J
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2013 Nov 14; Vol. 8 (11), pp. e80239. Date of Electronic Publication: 2013 Nov 14 (Print Publication: 2013).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    CD4-Positive T-Lymphocytes/*immunology
    Dendritic Cells/*immunology
    Epitopes, T-Lymphocyte/*immunology
    Factor VIII/*immunology
    HLA-DRB1 Chains/*immunology
    Peptides/*immunology
    Amino Acid Sequence ; Antigen Presentation ; CD4-Positive T-Lymphocytes/cytology ; Cells, Cultured ; Dendritic Cells/cytology ; Endocytosis/immunology ; Epitopes ; Epitopes, T-Lymphocyte/chemistry ; Factor VIII/chemistry ; HLA-DRB1 Chains/chemistry ; Humans ; Immunophenotyping ; Macrophages/cytology ; Macrophages/immunology ; Mass Spectrometry ; Molecular Sequence Data ; Peptides/chemistry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
    Autorzy:
    van Helden PM; Department of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory and Van Creveld Laboratory, Amsterdam, The Netherlands.
    Van Haren SD
    Fijnvandraat K
    van den Berg HM
    Voorberg J
    Pokaż więcej
    Źródło:
    Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2010 May; Vol. 16 (102), pp. 35-43.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Immune Tolerance*
    B-Lymphocytes/*immunology
    Factor VIII/*immunology
    Hemophilia A/*immunology
    Immunologic Memory/*immunology
    Blood Coagulation Factor Inhibitors/metabolism ; Enzyme-Linked Immunosorbent Assay ; Factor VIII/therapeutic use ; Hemophilia A/therapy ; Humans ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies